Some women who receive treatment for breast cancer also face higher heart risks. However, with good management these risks are generally reversible, according to a study published in the Journal of Clinical Oncology, August 14 issue.

There are two articles in the latest issue of the journal, and they stress the importance of monitoring breast cancer patients who take Herceptin as well as those undergoing radiotherapy.

Link